Related Experiment Videos
Clinical interventions for the preservation of ischemic myocardium
Insights
Clinical understanding of myocardial mechanical function and oxygen needs aids acute myocardial infarction patients. New therapeutic interventions show promise in supporting ischemic heart muscle and reducing damage.
Area of Science:
- Cardiology
- Cardiovascular Physiology
Background:
- Understanding myocardial mechanical function and oxygen demands is crucial for treating acute myocardial infarction.
- Clinical applications are emerging for patients experiencing heart attacks.
Purpose of the Study:
- To review the application of clinical understanding of myocardial determinants in acute myocardial infarction.
- To highlight the availability of techniques and agents for therapeutic interventions.
Main Methods:
- Utilizing invasive and noninvasive techniques to quantify hemodynamic parameters (afterload, contractile state, preload, heart rate).
- Assessing the metabolic state and infarct size.
- Evaluating therapeutic interventions for acute myocardial infarction.
Main Results:
- Techniques are available to quantitate key determinants of cardiac function and metabolic state.
- A growing list of therapeutic interventions can be evaluated using these methods.
- Pharmacologic and metabolic agents show potential for supporting ischemic myocardium.
Conclusions:
- The clinical understanding of myocardial function determinants is applicable to acute myocardial infarction.
- Available techniques and agents offer promising therapeutic strategies.
- Interventions aimed at supporting ischemic myocardium may reduce infarct size and improve outcomes.
Abstract:
The clinical understanding of determinants of mechanical function and oxygen requirements of the myocardium have now been applied to the patient with acute myocardial infarction. Invasive and noninvasive techniques to quantitate afterload, contractile state, preload, and heart rate as well as to assess the metabolic state and infarct size are now available to evaluate a growing list of therapeutic interventions. Thus, the availability of pharmacologic and metabolic agents to support ischemic myocardium and to reduce the eventual loss of contracting myocardium appears promising to the patient with acute myocardial infarction.